An International, Open Label, Randomised Controlled Trial Comparing Rituximab With Azathioprine as Maintenance Therapy in Relapsing ANCA-associated Vasculitis

Trial Profile

An International, Open Label, Randomised Controlled Trial Comparing Rituximab With Azathioprine as Maintenance Therapy in Relapsing ANCA-associated Vasculitis

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Rituximab (Primary) ; Azathioprine
  • Indications Anti-neutrophil cytoplasmic antibody-associated vasculitis
  • Focus Registrational; Therapeutic Use
  • Acronyms RITAZAREM
  • Most Recent Events

    • 21 Feb 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
    • 26 Jan 2017 This trial has been completed in Italy.
    • 20 Jan 2017 This trial was completed in Ireland, according to European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top